Literature DB >> 31654153

Immunohistochemical assessment of Eph/ephrin expression in oral squamous cell carcinoma and precursor lesions.

Hiroki Saito1,2, Mariko Oikawa3, Atsumu Kouketsu4,3, Tetsu Takahashi4, Hiroyuki Kumamoto3.   

Abstract

To evaluate erythropoietin-producing hepatocellular carcinoma (Eph)/Eph receptor-interaction protein (ephrin) expression in oral squamous cell carcinoma (OSCC) and oral epithelial precursor lesions (OEPLs), EphA2, EphB4, and ephrinB2 were examined and compared with microvessel density (MVD) and lymphatic vessel density (LVD). Samples from 73 OSCC and 43 OEPLs patients were immunohistochemically analyzed with antibodies against EphA2, EphB4, ephrinB2, CD34, and D2-40. Results were compared with clinicopathological findings. Immunohistochemical reactivity for EphA2, EphB4, and ephrinB2 was detected in epithelial cells and some stromal vascular cells in OEPLs and OSCC, proportionately with the level of malignancy. The number of blood vessel endothelial cells stained with CD34 and lymphatic vessel endothelial cells stained with D2-40 was increased in OEPLs and OSCC. In OSCC, ephrinB2 and EphB4 exhibited significant correlation with recurrence and invasion depth, respectively. MVD was significantly lower in slight lymphocytic reaction than in prominent stromal reaction. Association was found between LVD and T classification, postoperative metastasis, survival, mode of invasion, and invasion depth. Expression of EphA2, EphB4, ephrinB2, MVD, and LVD might be associated with malignant potential of the oral epithelium. Angiogenesis and lymphangiogenesis appear to be related to progression of potentially malignant oral lesions.

Entities:  

Keywords:  EphA2; EphB4; Oral epithelial precursor lesions; Oral squamous cell carcinoma; ephrinB2

Mesh:

Substances:

Year:  2019        PMID: 31654153     DOI: 10.1007/s10266-019-00466-y

Source DB:  PubMed          Journal:  Odontology        ISSN: 1618-1247            Impact factor:   2.634


  29 in total

1.  Distribution of EphB4 and EphrinB2 in normal and malignant urogenital tissue.

Authors:  Enver Ozgür; Axel Heidenreich; Oguzhan Dagtekin; Udo Engelmann; Wilhelm Bloch
Journal:  Urol Oncol       Date:  2009-03-09       Impact factor: 3.498

2.  Intratumoral lymphatic vessel density in vulvar squamous cell carcinomas: a possible association with favorable prognosis.

Authors:  Renata Sampaio Goes; Jesus P Carvalho; Bernardo G L Almeida; Carlos E Bacchi; Joao Carlos Sampaio Goes; Marcelo Alvarenga Calil; Edmund C Baracat; Filomena M Carvalho
Journal:  Int J Gynecol Pathol       Date:  2012-01       Impact factor: 2.762

3.  The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization.

Authors:  K Ogawa; R Pasqualini; R A Lindberg; R Kain; A L Freeman; E B Pasquale
Journal:  Oncogene       Date:  2000-12-07       Impact factor: 9.867

4.  Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis.

Authors:  Yukihiro Saito; Hironori Nakagami; Ryuichi Morishita; Yoichi Takami; Yasushi Kikuchi; Hiroki Hayashi; Tomoyuki Nishikawa; Katsuto Tamai; Nobuyoshi Azuma; Tadahiro Sasajima; Yasufumi Kaneda
Journal:  Circulation       Date:  2006-09-04       Impact factor: 29.690

5.  Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.

Authors:  M S O'Reilly; T Boehm; Y Shing; N Fukai; G Vasios; W S Lane; E Flynn; J R Birkhead; B R Olsen; J Folkman
Journal:  Cell       Date:  1997-01-24       Impact factor: 41.582

6.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

Authors:  N Weidner; J P Semple; W R Welch; J Folkman
Journal:  N Engl J Med       Date:  1991-01-03       Impact factor: 91.245

7.  Characterization, Localization and Patterning of Lymphatics and Blood Vessels in Oral Squamous Cell Carcinoma: A Comparative Study Using D2-40 and CD-34 IHC Marker.

Authors:  Deshant Agarwal; Nilesh Pardhe; Manas Bajpai; Shailendra Gupta; Nikunj Mathur; S S Vanaki; R S Puranik; Manoj Mittal
Journal:  J Clin Diagn Res       Date:  2014-10-20

8.  Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.

Authors:  Syed Mahfuzul Alam; Jiro Fujimoto; Israt Jahan; Eriko Sato; Teruhiko Tamaya
Journal:  Gynecol Oncol       Date:  2009-04-08       Impact factor: 5.482

9.  Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.

Authors:  H U Wang; Z F Chen; D J Anderson
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

10.  Immunohistochemical study of vascular endothelial growth factor-C/vascular endothelial growth factor receptor-3 expression in oral tongue squamous cell carcinoma: Correlation with the induction of lymphangiogenesis.

Authors:  Tomofumi Naruse; Souichi Yanamoto; Shin-Ichi Yamada; Hidenori Takahashi; Yuki Matsushita; Naomi Imayama; Hisazumi Ikeda; Takeshi Shiraishi; Shuichi Fujita; Tohru Ikeda; Izumi Asahina; Masahiro Umeda
Journal:  Oncol Lett       Date:  2015-08-04       Impact factor: 2.967

View more
  1 in total

1.  Immunohistochemical and immunofluorescence expression profile of lymphatic endothelial cell markers in oral cancer.

Authors:  Kullasit Chutipongpisit; V Praveen Parachuru; Lara T Friedlander; Haizal M Hussaini; Alison M Rich
Journal:  Int J Exp Pathol       Date:  2021-11-17       Impact factor: 1.925

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.